```json
{
"content": [
{
"type": "paragraph",
"content": "North America leads the Non-Fibered Embolization Coils market, capturing 45% of global revenue. The region benefits from advanced healthcare infrastructure, high adoption of minimally invasive procedures, and robust R&D investments by market leaders. Regulatory support for innovative devices and a strong reimbursement ecosystem further drive growth."
},
{
"type": "paragraph",
"content": "Europe maintains a 30% market share, driven by mature healthcare systems, stringent safety regulations, and rising prevalence of cerebrovascular diseases. Countries like Germany and France leverage advanced neurosurgical infrastructure, while the UK’s NHS prioritizes cost-effective, patient-centric treatments, boosting adoption."
},
{
"type": "paragraph",
"content": The Asia Pacific region is the fastest-growing, projected to expand at a CAGR of 8.5% through 2030. Key drivers include urbanization, rising healthcare awareness, and expanding neurosurgery training programs. Japan and South Korea lead in technological adoption, while India and China benefit from government investments in hospital infrastructure and affordable treatment access."
},
{
"type": "paragraph",
"content": "Latin America holds 7% of the market, with growth fueled by improving healthcare access in Brazil and Mexico and increasing partnerships with global manufacturers. Middle East & Africa, at 3%, is driven by strategic healthcare reforms in the Gulf and rising neuroendovascular capabilities in sub-Saharan Africa."
}
],
"worldMapData": {
"regions": [
{ "name": "North America", "value": 45 },
{ "name": "Europe", "value": 30 },
{ "name": "Asia Pacific", "value": 15 },
{ "name": "Latin America", "value": 7 },
{ "name": "Middle East & Africa", "value": 3 }
]
}
}
```
